Our Approach

OUR APPROACH

Innovative architecture for clinical trials

Platform Life Sciences delivers modern end-to-end clinical trials with speed and efficiency through our adaptive platform and sustainable development model.

We operate in five continents and are able to recruit patients fast, with a high level of patient adherence and follow-up. We are connected to over 100 clinical sites that are linked to outpatient clinics, universities and academic centers.

Move forward faster

Swiftly receive the evidence you need through our adaptive platform.

Get timely data

Collect massive amounts of data efficiently with our digital and global health centers infrastructure.

Go global

Tap our global and local expert knowledge and recruitment to progress further, faster.

Our Value

There’s a better way to do clinical trials

We’ve redesigned the entire workflow to make Phase II/III clinical trials more efficient while helping you save your resources.

Empowering industries across the globe

Biotech / Pharma

Consortiums / Foundations

Government Agencies

Biotechnology and pharmaceutical industries

Our services

Rely on Platform Life Sciences for any stage of your phase II/III clinical trial. We offer end-to-end solutions, individual packages, or custom packages depending on your needs.

01

Feasibility

We assessed individual sites for capabilities to perform the master protocol.
02

Master Protocol

We designed a master protocol to allow the easy addition and removal of new intervention arms.
03

Recruitment

We operate in five continents and are able to recruit patients fast, with a high level of patient adherence and follow-up. We are connected to over 100 clinical sites that are linked to outpatient clinics, universities and academic centers.
04

Data Management

We use Veeva and distributed systems with automated workflows to optimize hybrid data collection, with best-in-class quality and digital infrastructure. Our global trials are designed to operate seamlessly with consistent and compliant data collection and reporting practices.
05

Analytic

We designed a Statistical Analysis Plan, completed analysis of all fully recruited evaluations and published findings of these results.
06

Regulatory Affairs and Quality Assurance

Our global platform has worked successfully with local regulators on all aspects of clinical trials. Our collective team has a long and established history of working with many regulatory bodies around the world.

Our Proof

TOGETHER Trial

This is the largest placebo-controlled outpatient trial for COVID-19 in the world, and we have tested more than 12 therapeutics in 22 months.

Successful COVID-19 trial when 95% failed

Largest running COVID-19 outpatient trial

Rapid response to global health needs

01

Feasibility

We assessed individual sites for capabilities to perform the master protocol.
02

Master Protocol

We designed a master protocol to allow the easy addition and removal of new intervention arms.
03

Recruitment

We operate in five continents and are able to recruit patients fast, with a high level of patient adherence and follow-up. We are connected to over 100 clinical sites that are linked to outpatient clinics, universities and academic centers.
04

Data Management

We use Veeva and distributed systems with automated workflows to optimize hybrid data collection, with best-in-class quality and digital infrastructure. Our global trials are designed to operate seamlessly with consistent and compliant data collection and reporting practices.
05

Analytic

We designed a Statistical Analysis Plan, completed analysis of all fully recruited evaluations and published findings of these results.
06

Regulatory Affairs and Quality Assurance

Our global platform has worked successfully with local regulators on all aspects of clinical trials. Our collective team has a long and established history of working with many regulatory bodies around the world.

Find More Information